Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374

NIL

Jahr

Publikationsjahr
2024

Autoren

Autorenliste der Publikation
Ziemssen T, Groth M, Winkelmann VE, Bopp T.

Verlag

Publisher-Information
Vaccines 2023, 11, 1374. Vaccines. 2024; 12(8):911.

Link

Zur Publikation (externer Server)
https://doi.org/10.3390/vaccines12080911

Tags

Forschungsthemen
Multiple SkleroseNeuroimmunologie
MSZNIL2024